TrialBMC gastroenterology2025

A randomized open label pilot study evaluating the efficacy of two dosing regimens of rifamycin SV MMX in the treatment of small intestinal bacterial overgrowth.

Bradley A Connor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.